-
The U.S. Department of Health and Human Services' Office of Inspector General (OIG) now expects research institutions to monitor their own regulatory compliance and identify errors and overpayments.
-
The Office for Human Research Protections (OHRP) of the U.S. Department of Health and Human Services has published online its 2011 edition of the "International Compilation of Human Research Protections."
-
Managing a clinical research department is challenging for a variety of reasons. One of the most difficult issues involves staffing communication and retention.
-
Genome research and accumulated knowledge is changing the way we understand disease and treatment, which, in turn, is changing clinical trials, an expert says.
-
-
Patients with localized but non-resectable lung cancer generally are considered candidates for other types of therapy including external beam or stereotactic radiation therapy, chemotherapy, or percutaneous ablation.
-
Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.
-
-
A 71-year-old retired police officer was admitted through the emergency room with right upper quadrant pain and low-grade fever.
-
Limited data are available to guide the decision between up-front allogeneic hematopoietic cell transplantation (HCT) or imatinib on long-term outcomes for accelerated phase chronic myelogenous leukemia (CML).